ID Practice Update

Short lecture / 10-20 minutes

Fever in the hospitalized patient

What should change when a hospitalized patient develops fever?

New inpatient fever, focused testing, and reassessment of infectious and noninfectious causes.

Resident discussion / Optional fellow section / Edited November 10, 2026

Optional fellow discussion is below

The short resident lecture comes first. Jump directly to the fellow discussion for additional detail.

This lecture is intended as a supplementary resource for clinicians and trainees to review evidence and discuss clinical cases.

Initial assessment of new inpatient fever

A 67-year-old develops a temperature of 38.6 C on hospital day 6 while receiving antibiotics for an abdominal infection. Blood pressure and oxygen requirements are unchanged. A drain and urinary catheter remain in place.

Discuss before reading on. Which findings would require immediate treatment? What would you review before changing antibiotics?

The initial assessment includes the temperature and how it was measured, blood pressure, oxygenation, mental status, perfusion, and urine output. The timing of symptoms, procedures, devices, medications, and prior cultures helps identify a source. Prolonged fever of unknown origin has a separate evaluation. [1]

The urgency depends on sepsis probability and organ dysfunction

Antimicrobial timing in the 2026 Surviving Sepsis Campaign adult guideline.
Clinical assessmentTiming and rationale
Possible, probable, or definite septic shock, or probable or definite sepsis without shockThe guideline recommends immediate antimicrobials, ideally within 1 hour of recognition. Resuscitation and source evaluation proceed in parallel as indicated.
Possible sepsis without shockA rapid evaluation helps distinguish infectious from noninfectious causes. If concern for infection persists, the guideline suggests starting antimicrobials within 3 hours of first suspecting sepsis.
Low likelihood of infection and no shockClose monitoring and reassessment may allow antimicrobials to be deferred. Fever alone is a poor basis for broadening existing therapy.

The guideline recommends early blood cultures, ideally before antimicrobials when sampling will not delay urgent treatment. The decision to start antimicrobials rests on clinical assessment. A procalcitonin result should not delay treatment for probable sepsis or suspected septic shock. [2]

Febrile neutropenia requires urgent empiric antibacterial therapy on a separate pathway. Fever with profound immunosuppression, suspected bacterial meningitis, or another time-sensitive syndrome warrants immediate senior assessment. [3] [7]

Which findings make a test useful?

Tests that can answer a specific clinical question.
Finding or concernFocused evaluation
Bacteremia or a central-line source is plausibleBlood cultures can establish bacteremia. If a catheter source is suspected, simultaneous catheter and peripheral draws with equal blood volumes and labeled collection sites allow comparison. Growth of the same organism at least 2 hours earlier from the catheter supports a catheter source. [8]
New cough, hypoxemia, or respiratory findingsRespiratory findings support chest imaging and testing guided by the syndrome and exposures. Chest radiography for new ICU fever is a best-practice statement in the SCCM/IDSA guideline.
Urinary findings or unexplained sepsisUrine testing is most informative when the presentation supports UTI. A catheter or pyuria alone does not establish a urinary source.
New unexplained diarrheaThe usual group for C. difficile testing has at least 3 new unformed stools in 24 hours without another explanation. Recent laxatives can confound that assessment.
Abdominal pain, ileus, abnormal drainage, or recent surgeryAbdominal and wound findings, drain function, and the adequacy of source control guide the choice of imaging with the procedural team.
[1] [5]

For suspected acute intra-abdominal abscess in a nonpregnant adult, the 2024 IDSA panel conditionally suggests CT as initial imaging based on very low-certainty evidence. IV contrast may improve visualization of the abscess wall. Patient factors and the clinical question inform the protocol. [4]

Formed stool is generally unsuitable for routine C. difficile testing. A positive result can persist after recovery, so repeat testing does not document cure. Fulminant CDI can present with ileus and little or no diarrhea. Urgent evaluation and treatment in that setting cannot wait for the usual stool threshold. [5]

Persistent fever can reflect a new source or a noninfectious process

How the history and examination change the differential.
PossibilityQuestion to ask at the bedside
Uncontrolled or newly acquired infectionIs a collection undrained, a device infected, or a new syndrome developing?
Medication reactionHow does the fever relate to a new medication? Drug fever can occur without rash or eosinophilia.
Thrombosis or pulmonary embolismAre there compatible symptoms or signs that justify directed testing?
Postoperative inflammation or tissue injuryDoes the clinical course fit the procedure and expected recovery? Postoperative timing alone cannot exclude infection.
Transfusion reaction or other inflammatory diseaseDoes the timing suggest a transfusion reaction, or are there other clues to an inflammatory disorder?
[1] [6]

The medication review includes non-antibiotics. Drug fever is a diagnosis of exclusion. Rash with organ injury raises concern for a serious drug reaction and warrants prompt evaluation. [1] [6]

Reassessment should produce a specific plan

In the opening case, the original diagnosis, prior cultures, antibiotic activity and exposure, drain output, and latest imaging frame the reassessment. A persistent abdominal source would raise the question of inadequate drainage for the surgical or interventional radiology team. Broader antibiotic coverage cannot compensate for an undrained infected collection. [2] [4]

Deterioration or a new localizing syndrome changes the urgency or likely source. In an improving patient without new evidence of infection, persistent fever alone is a poor basis for broadening. Review of the original indication and subsequent findings can identify therapy that is no longer needed. [2]

Example handoff. "New fever without current hemodynamic or respiratory deterioration. The team is checking the abdominal source and drain. Hypotension, increasing oxygen need, or altered mentation would prompt immediate reassessment."

What changes the plan at the bedside?

Stability and immune status set the urgency. The likely source determines which tests might change treatment. A clear handoff names the current plan and findings that would prompt escalation.

What the ICU guidance covers

The 2023 SCCM/IDSA guideline covers new fever in adult ICU patients without severe immunocompromise. Its graded recommendations are weak, alongside several best-practice statements. The ward approach in this module is a clinical adaptation. [1]

When blood cultures are indicated in an adult ICU patient, the guideline advises collecting at least two sets in sequence from separate sites without waiting between draws. For a febrile ICU patient with pyuria and suspected UTI who has a urinary catheter, the guideline recommends replacing the catheter and obtaining the specimen from the new catheter. Pyuria or catheter presence alone is insufficient to establish a urinary source. [1]

The guideline weakly advises against routine antipyretics solely to lower temperature in critically ill adults. Antipyretics can be considered when the patient values relief of fever-related discomfort. [1]

An unrevealing initial evaluation gives the team a reason to revisit the history and examination. The guideline weakly suggests FDG-PET/CT in selected critically ill adults after other testing fails to identify a cause and when transport risk is acceptable. The evidence is very low quality. [1]

Discussion variation. The temperature is unchanged, but the patient now has hypotension and confusion. How does that change the urgency before the source is known? [2]

Sources and further reading

1. SCCM/IDSA. Evaluating new fever in adult patients in the ICU. 2023.

2. Surviving Sepsis Campaign. Adult guidelines. 2026.

3. Freifeld AG, et al. IDSA guideline for antimicrobial use in neutropenic patients with cancer. 2010 update, published 2011.

4. IDSA. Complicated intra-abdominal infections, diagnostic evaluation. 2024.

5. SHEA/IDSA. C. difficile infection guideline, diagnostic recommendations. 2017 update.

6. Khan DA, et al. Drug allergy practice parameter update. 2022. See also Someko H, et al. Drug fever, 2023 narrative review, for the limitations of rash and eosinophilia as diagnostic clues.

7. NICE. Bacterial meningitis and meningococcal disease. 2024.

8. Mermel LA, et al. IDSA guideline for intravascular catheter-related infection. 2009. Archived guideline and update status.

The cases are fictional. Clinical application depends on the patient and local protocols.